Cite
HARVARD Citation
Meininger, V. et al. (n.d.). Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet neurology. 16 (3), pp. 208-216. [Online].